orthocell
-
Hospitals
Orthocell Secures New Patent for Suture-Less Repair of Soft Tissue
January 17, 2018 PERTH, Australia–(BUSINESS WIRE)–Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce it…
Read More » -
Hospitals
Orthocell Granted European Tendon Regeneration Patent
December 14, 2017 PERTH, Australia–(BUSINESS WIRE)–Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce it…
Read More » -
Biologics
Orthocell Appoints Surgical Specialties as Exclusive Distributor
October 10, 2017 PERTH, Australia–(BUSINESS WIRE)–Regenerative medicine company Orthocell Limited (ASX:OCC, “Orthocell” or the “Company”) is pleased to announce it…
Read More » -
Sports Medicine
1st Patient Recruited in Orthocell Ortho-ATI® Shoulder Tendon Study
September 04, 2017 PERTH, Australia–(BUSINESS WIRE)–Regenerative medicine company Orthocell Limited (ASX:OCC) today announced that it has recruited and treated its…
Read More » -
Biologics
Ortho-ACI® Included on the Australian Register of Therapeutic Goods
May 31, 2017 PERTH, Australia–(BUSINESS WIRE)–Regenerative medicine company Orthocell Limited (“Orthocell or Company”) is pleased to announce it has received…
Read More » -
Sports Medicine
Orthocell Announces Collaboration with Johnson & Johnson Innovation
January 11, 2017 PERTH, Australia–(BUSINESS WIRE)–Regenerative medicine company Orthocell Limited has today announced a research collaboration agreement with DePuy Synthes…
Read More » -
Biologics
Orthocell Receives Approval for Human Nerve Regeneration Study Using CelGro®
October 17, 2016 PERTH, Australia–(BUSINESS WIRE)–Regenerative medicine company Orthocell has been granted ethics approval for a human study examining the…
Read More » -
Sports Medicine
Orthocell Receives Ethics Approval For Pivotal Ortho-ATI Tendon Study
7/12/2016 Perth, Australia; 12 July 2016: Regenerative medicine company Orthocell Limited today announced that it has received ethics approval…
Read More » -
Biologics
Orthocell receives ethics approval for collagen scaffold study
By Life Scientist Staff – Wednesday, 04 May, 2016 Regenerative medicine company Orthocell (ASX:OCC) has been granted ethical approval by St…
Read More » -
Biologics
First patients treated with Orthocell’s tendon repair therapy in Hong Kong
Regenerative medicine company Orthocell Limited has announced it has expanded its presence in Asia with the first patients treated with…
Read More » -
Biologics
Orthocell receives U.S. patent for soft tissue repair technology
Regenerative medicine company Orthocell (ASX:OCC) has received a U.S. patent covering the manufacture of its Celgro collagen-based scaffold for the…
Read More » -
Biologics
Orthocell receives Chinese patent covering its Celgro™ soft tissue reconstructive medical device platform technology
Orthocell granted Chinese patent for method to manufacture Celgro™ collagen medical device platform technology Patent relates to manufacture of…
Read More » -
Extremities
Clinical study shows long-term effectiveness of Orthocell’s Ortho-ATI™ for treatment resistant tennis elbow
Regenerative medicine company Orthocell Limited has today released results from a long-term clinical study into its Ortho-ATI™ treatment for tennis elbow that provides evidence…
Read More »